Prelude Therapeutics Inc

SEC 4 · Filed

0001620368-26-000003Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 9, 2026

Grant, award or other acquisition by Sandor Victor

Security
Director Stock Option (Right to Buy)
Code
A
Shares
38,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-09",
  "direction": "A",
  "exercise_price": "3.94",
  "expiration": "2036-06-08",
  "footnotes": {
    "F1": "The option award will fully vest upon the earlier of (a) the Issuer\u0027s next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person\u0027s provision of service to the Issuer on each vesting date."
  },
  "owners": [
    {
      "cik": "0001620368",
      "name": "Sandor Victor",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "38000.00",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Director Stock Option (Right to Buy)",
  "shares": "38000.00",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "38000.00"
}